Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Rea, Daniel"" wg kryterium: Autor


Wyświetlanie 1-20 z 20
Tytuł:
HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancer
Autorzy:
Evans, Abigail
Ball, Adrian
Johri, Akhil
Nejim, Ali
Jones, Alison
Corder, Allan
Thorne, Amanda
Anand, Ambika
Chakrabarti, Amitabha
Robinson, Anne
Skene, Anthony
Modi, Anupam
Patel, Ashraf
Kothari, Ashutosh
McFall, Brendan
Mortimer, Caroline
Lee, Caroline
Chan, Charlie
Abson, Charlotte
Holcombe, Christopher
Hinton, Christopher
Hollywood, Ciaran
Murphy, Claire
Crowley, Clare
Harding-Mackean, Claudia
Griffith, Clive
Lewanski, Conrad
Rea, Daniel
Hwang, David
Crawford, Derek
Thekkinkattil, Dinesh
Ferguson, Douglas
Adamson, Douglas
Wheatley, Duncan
Ravichandran, Duraisamy
Babu, Ed
Hyett, Elaine
Ashkanani, Fawzia
Hoar, Fiona
Kenny, Frances
Dyke, Gary
Sparrow, Geoffrey
Gilbert
Cunnick, Giles
Algurafi, Hafiz
Sweetland, Helen
Prof, Highes-Davies
Hamed, Hisham
Smith, Ian
Laidlaw, Ian
Khattak, Ilyas
Newby, Jacqueline
Rees-Lee, Jacqueline
Kokan, Jalal
Barrett, Jane
Naik, Jay Dolatrai
Vaidya, Jayant
Forrest, Jennifer
Parmar, Jitendra
Adams, Jocelyn
Fox, John
Roberts, Jonathan
Dawson, Jonathan
Doughty, Julie
Donnelly, Jull
Dunn, Kathleen
Chin, Kian
Horgan, Kieran
Thakur, Kislaya
Barthelmes, Ludger
Wyld, Lynda
Bhattacharyya, Madhumita
Hadaki, Maher
Kishore, Makam
Ornstein, Marcus
Bramley, Maria
Bews-Hair, Maria
Parton, Marina
Sibbering, Mark
Kissin, Mark
Churn, Mark
Hogg, Martin
Quigley, Mary
Hatton, Matthew
Winter, Matthew
Adelekan, Matthew
Shere, Michael
Carr, Michael
Williams, Michael
Absar, Mohammed
Sharif, Muhammad
Kelleher, Muireann
Walji, Nawaz
Williams, Nicholas
Gallegos, Nicholas
Bundred, Nigel
Hatcher, Olivia
Crellin, Perric
Crane, Peter
Donnelly, Peter
Kneeshaw, Peter
Walker, Philip
Sinha, Prakash
Bhaskar, Pudhupalayam
Soulsby, Racheal
Todd, Radha
Vidya, Raghavan
Mehra, Rakesh
Prasad, Ramachandran
Cutress, Ramsay
Sharma, Ravi
Roylance, Rebecca
Goranova, Rebecca
Salman, Reem Ramzi
Bonom, Riccardo
Johnson, Richard
Sutton, Richard
Linforth, Rick
Coleman, Rob
Grieve, Robert
Leonard, Robert
Reichert, Robert
Kennedy, Robert
Agarwal, Roshan
Allerton, Rozenn
Burcombe, Russell
Davis, Ruth
Narayanan, Sankaran
Chandrasekharan, Sankaran
Vesty, Sarah
Seetharam, Seema
Ledwidge, Serena
Iqbal, Shabana
Wahee, Shamaela
Silva, Shobha
Pain, Simon
Holt, Simon
Thomson, Simon
Smith, Simon
Ellenbogen, Simon
Laws, Siobhan
Chan, Stephen
Johnston, Stephen
Holt, Steve
Thrush, Steven
McIntosh, Stuart
Chatterjee, Sumohan
Cleator, Susan
Usman, Tamoor
Johnson, Tayo
Kovacs, Tibor
Irvine, Tracey
Barthkur, Urmila
Pope, Vanessa
Brown, Victoria Alexandra
Muralikrishna, Vummiti
Samra, Walid
Maxwell, William
Winters, Zoe
Bergamino, Milana A.
López-Knowles, Elena
Morani, Gabriele
Tovey, Holly
Kilburn, Lucy
Schuster, Eugene F.
Alataki, Anastasia
Hills, Margaret
Xiao, Hui
Holcombe, Chris
Robertson, John F.
Smith, Ian E.
Bliss, Judith M.
Dowsett, Mitch
Cheang, Maggie C.U.
Pokaż więcej
Źródło:
In eBioMedicine September 2022 83
Czasopismo naukowe
Tytuł:
P139: Uptake of Cyclin Dependant Kinase 4/6 inhibitors (CDKi) - A retrospective audit at University Hospital Birmingham trust (UHB) (audit approval number: Carms15507).
Autorzy:
Chatterjee, Shaunak
Basu, Naren
Crichton, Katherine
Steven, Jane
Stevens, Andrea
Rea, Daniel
Pokaż więcej
Temat:
UNIVERSITY hospitals
KINASE inhibitors
CYCLINS
CYCLIN-dependent kinases
Źródło:
European Journal of Surgical Oncology; Jun2020, Vol. 46 Issue 6, pe47-e48, 2p
Przedsiębiorstwo/ jednostka:
UNIVERSITY of Colorado Hospital
Czasopismo naukowe
Czasopismo naukowe
Tytuł:
OPTIMA (Optimal Personalised Treatment of early breast cancer using Multi-parameter Analysis): A prospective trial to validate the predictive utility and cost-effectiveness of gene expression test-directed chemotherapy decisions.
Autorzy:
Francis, Adele
Stein, Robert C.
Marshall, Andrea
Rea, Daniel W.
Cameron, David A.
Macpherson, Iain R.
Earl, Helena M.
Poole, Christopher J.
Hall, Peter S.
Bartlett, John M.S.
Rooshenas, Leila
Morgan, Adrienne
Harmer, Victoria
Donovan, Jenny
Hulme, Claire
McCabe, Christopher
Pinder, Sarah E.
Hughes-Davies, Luke
Makris, Andreas
Dunn, Janet A.
Pokaż więcej
Temat:
BREAST cancer patients
BREAST cancer surgery
BREAST cancer treatment
GENE expression
CANCER chemotherapy
Źródło:
European Journal of Surgical Oncology; May2016, Vol. 42 Issue 5, pS9-S10, 1p
Czasopismo naukowe
Tytuł:
O-85 What do clinicians in the UK do once a patient has received 5 years of adjuvant hormonal Aromatase Inhibitor (AI) containing treatment?
Autorzy:
Gaunt, Claire
Rea, Daniel
Pokaż więcej
Źródło:
EJC Supplements; Sep2010, Vol. 8 Issue 6, p32-32, 1p
Czasopismo naukowe
Tytuł:
Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial.
Autorzy:
Turner, Nicholas C (AUTHOR)
Kingston, Belinda (AUTHOR)
Kilburn, Lucy S (AUTHOR)
Kernaghan, Sarah (AUTHOR)
Wardley, Andrew M (AUTHOR)
Macpherson, Iain R (AUTHOR)
Baird, Richard D (AUTHOR)
Roylance, Rebecca (AUTHOR)
Stephens, Peter (AUTHOR)
Oikonomidou, Olga (AUTHOR)
Braybrooke, Jeremy P (AUTHOR)
Tuthill, Mark (AUTHOR)
Abraham, Jacinta (AUTHOR)
Winter, Matthew C (AUTHOR)
Bye, Hannah (AUTHOR)
Hubank, Michael (AUTHOR)
Gevensleben, Heidrun (AUTHOR)
Cutts, Ros (AUTHOR)
Snowdon, Claire (AUTHOR)
Rea, Daniel (AUTHOR)
Pokaż więcej
Źródło:
Lancet Oncology. Oct2020, Vol. 21 Issue 10, p1296-1308. 13p.
Czasopismo naukowe
Tytuł:
Synchronous versus sequential chemo-radiotherapy in patients with early stage breast cancer (SECRAB): A randomised, phase III, trial.
Autorzy:
Fernando, Indrajit N. (AUTHOR)
Bowden, Sarah J. (AUTHOR)
Herring, Kathryn (AUTHOR)
Brookes, Cassandra L. (AUTHOR)
Ahmed, Ikhlaaq (AUTHOR)
Marshall, Andrea (AUTHOR)
Grieve, Robert (AUTHOR)
Churn, Mark (AUTHOR)
Spooner, David (AUTHOR)
Latief, Talaat N. (AUTHOR)
Agrawal, Rajiv K. (AUTHOR)
Brunt, Adrian M. (AUTHOR)
Stevens, Andrea (AUTHOR)
Goodman, Andrew (AUTHOR)
Canney, Peter (AUTHOR)
Bishop, Jill (AUTHOR)
Ritchie, Diana (AUTHOR)
Dunn, Janet (AUTHOR)
Poole, Christopher J. (AUTHOR)
Rea, Daniel W. (AUTHOR)
Pokaż więcej
Źródło:
Radiotherapy & Oncology. Jan2020, Vol. 142, p52-61. 10p.
Czasopismo naukowe
Tytuł:
Adjuvant tamoxifen and exemestane in women with postmenopausal early breast cancer (TEAM): 10-year follow-up of a multicentre, open-label, randomised, phase 3 trial.
Autorzy:
Derks, Marloes G M
Blok, Erik J
Seynaeve, Caroline
Nortier, Johan W R
Kranenbarg, Elma Meershoek-Klein
Liefers, Gerrit-Jan
Putter, Hein
Kroep, Judith R
Rea, Daniel
Hasenburg, Annette
Markopoulos, Christos
Paridaens, Robert
Smeets, Jan B E
Dirix, Luc Y
van de Velde, Cornelis J H
Pokaż więcej
Źródło:
Lancet Oncology. Sep2017, Vol. 18 Issue 9, p1211-1220. 10p.
Czasopismo naukowe
Tytuł:
HER2 status predicts for upfront AI benefit: A TRANS-AIOG meta-analysis of 12,129 patients from ATAC, BIG 1-98 and TEAM with centrally determined HER2.
Autorzy:
Bartlett, John M.S.
Ahmed, Ikhlaaq
Regan, Meredith M.
Sestak, Ivana
Mallon, Elizabeth A.
Dell'Orto, Patrizia
Thürlimann, Beat
Seynaeve, Caroline
Putter, Hein
Van de Velde, Cornelis J.H.
Brookes, Cassandra L.
Forbes, John F.
Viale, Giuseppe
Cuzick, Jack
Dowsett, Mitchell
Rea, Daniel W. d.w.rea@bham.ac.uk
Pokaż więcej
Źródło:
European Journal of Cancer. Jul2017, Vol. 79, p129-138. 10p.
Czasopismo naukowe
Tytuł:
Addition of gemcitabine to paclitaxel, epirubicin, and cyclophosphamide adjuvant chemotherapy for women with early-stage breast cancer (tAnGo): final 10-year follow-up of an open-label, randomised, phase 3 trial.
Autorzy:
Earl, Helena M
Hiller, Louise
Howard, Helen C
Dunn, Janet A
Young, Jennie
Bowden, Sarah J
McDermaid, Michelle
Waterhouse, Anna K
Wilson, Gregory
Agrawal, Rajiv
O'Reilly, Susan
Bowman, Angela
Ritchie, Diana M
Goodman, Andrew
Hickish, Tamas
McAdam, Karen
Cameron, David
Dodwell, David
Rea, Daniel W
Caldas, Carlos
Pokaż więcej
Źródło:
Lancet Oncology. Jun2017, Vol. 18 Issue 6, p755-769. 15p.
Czasopismo naukowe
Tytuł:
Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): an open-label, randomised, phase 3 trial.
Autorzy:
Earl, Helena M
Hiller, Louise
Dunn, Janet A
Blenkinsop, Clare
Grybowicz, Louise
Vallier, Anne-Laure
Abraham, Jean
Thomas, Jeremy
Provenzano, Elena
Hughes-Davies, Luke
Gounaris, Ioannis
McAdam, Karen
Chan, Stephen
Ahmad, Rizvana
Hickish, Tamas
Houston, Stephen
Rea, Daniel
Bartlett, John
Caldas, Carlos
Cameron, David A
Pokaż więcej
Źródło:
Lancet Oncology. Jun2015, Vol. 16 Issue 6, p656-666. 11p.
Czasopismo naukowe
Tytuł:
Effect of local therapy on locoregional recurrence in postmenopausal women with breast cancer in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial.
Autorzy:
van Hezewijk, Marjan
Bastiaannet, Esther
Putter, Hein
Scholten, Astrid N.
Liefers, Gerrit-Jan
Rea, Daniel
Hasenburg, Annette
Paridaens, Robert
Hozumi, Yasuo
Markopoulos, Christos
Seynaeve, Caroline
Jones, Stephen E.
Marijnen, Corrie A.M.
van de Velde, Cornelis J.H.
Pokaż więcej
Źródło:
Radiotherapy & Oncology. Aug2013, Vol. 108 Issue 2, p190-196. 7p.
Czasopismo naukowe
Tytuł:
Predictive markers of anthracycline benefit: a prospectively planned analysis of the UK National Epirubicin Adjuvant Trial (NEAT/BR9601)
Autorzy:
Bartlett, John MS
Munro, Alison F
Dunn, Janet A
McConkey, Christopher
Jordan, Sarah
Twelves, Chris J
Cameron, David A
Thomas, Jeremy
Campbell, Fiona M
Rea, Daniel W
Provenzano, Elena
Caldas, Carlos
Pharoah, Paul
Hiller, Louise
Earl, Helena
Poole, Christopher J
Pokaż więcej
Źródło:
Lancet Oncology. Mar2010, Vol. 11 Issue 3, p266-274. 9p.
Czasopismo naukowe
    Wyświetlanie 1-20 z 20

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies